Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hua Medicine ( (HK:2552) ) has provided an announcement.
Hua Medicine announced the successful passing of all resolutions at its Annual General Meeting held on June 26, 2025. Key resolutions included the re-election of directors, reappointment of auditors, and granting of mandates for share repurchase and issuance. These decisions reflect strong shareholder support and are expected to enhance the company’s governance and operational flexibility.
More about Hua Medicine
Hua Medicine is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies for diabetes. The company is listed on the Hong Kong Stock Exchange under the stock code 2552.
Average Trading Volume: 5,176,878
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.82B
For an in-depth examination of 2552 stock, go to TipRanks’ Overview page.